Common blood pressure drug shows promise for treating ADHD symptoms
-
This could be a good new option for those with ADHD who are currently on meds for it.
-
This could be a good new option for those with ADHD who are currently on meds for it.
This is really interesting. As I was reading the article I was wondering how they were going to wring money out of it, as amlodipine is off patent. Then I got to this part:
“While amlodipine shows promise in preclinical models, it is not currently suitable for use in ADHD in its marketed form,” Karlsson noted. “Further optimization through chemical modification is necessary to enhance CNS selectivity and ensure a favorable therapeutic index in the context of ADHD.”
Classic big pharma. Slightly tweak an existing drug in an insignificant way so that you can get a new patent on it and charge exorbitant prices.
-
This is really interesting. As I was reading the article I was wondering how they were going to wring money out of it, as amlodipine is off patent. Then I got to this part:
“While amlodipine shows promise in preclinical models, it is not currently suitable for use in ADHD in its marketed form,” Karlsson noted. “Further optimization through chemical modification is necessary to enhance CNS selectivity and ensure a favorable therapeutic index in the context of ADHD.”
Classic big pharma. Slightly tweak an existing drug in an insignificant way so that you can get a new patent on it and charge exorbitant prices.
I have Adha and hypertension. As such I have an unused bottle of amlodapine at home. I'll take it and report back
Update: it's been 5 days and as much as I thought this medicine wouldn't do anything to help my adhd, it has. I'm on the lowest dose of amlodapine possible as such I need to talk with my Dr to see if i can increase. The only downfall is, is that it doesn't help with energy levels like sone of the stimulants do, however it definitely helps with motivation and concentration. I'll continue on until I finish tge bottle and will make a final update in 24 days. Early indications are promising though
